================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of report: September 26, 2003
Date of earliest event reported: September 24, 2003
BRISTOL-MYERS SQUIBB COMPANY
(Exact name of registrant as specified in its charter)
Delaware 1-1136 22-079-0350
(State or other jurisdiction (Commission file (IRS Employer
of incorporation) number) Identification Number)
345 Park Avenue
New York, NY 10154
(Address of principal executive office)
Registrant's telephone number, including area code: (212) 546-4000
================================================================================
Item 7 (c). Exhibits
Exhibit 99 - Press release of Bristol-Myers Squibb Company dated September 24,
2003 announcing the intention to offer convertible senior debentures.
Item 9. Regulation FD Disclosure
On September 24, 2003, Bristol-Myers Squibb Company issued a press release
announcing the intention to offer $1 billion of convertible senior debentures. A
copy of the press release is furnished as Exhibit 99 to this report and is
incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Bristol-Myers Squibb Company,
By: /s/ Sandra Leung
-------------------------------------
Name: Sandra Leung
Title: Secretary
Date: September 26, 2003
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
----------- -----------
99 Press Release dated September 24, 2003 of Bristol-Myers
Squibb Company